These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25965393)

  • 1. Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma.
    Sundarasetty BS; Chan L; Darling D; Giunti G; Farzaneh F; Schenck F; Naundorf S; Kuehlcke K; Ruggiero E; Schmidt M; von Kalle C; Rothe M; Hoon DS; Gerasch L; Figueiredo C; Koehl U; Blasczyk R; Gutzmer R; Stripecke R
    Gene Ther; 2015 Sep; 22(9):707-20. PubMed ID: 25965393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy.
    Pincha M; Sundarasetty BS; Salguero G; Gutzmer R; Garritsen H; Macke L; Schneider A; Lenz D; Figueiredo C; Blasczyk R; Ruggiero E; Schmidt M; von Kalle C; Puff C; Modlich U; von der Leyen H; Wicke DC; Ganser A; Stripecke R
    Hum Gene Ther Methods; 2012 Feb; 23(1):38-55. PubMed ID: 22428979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines.
    Koya RC; Kimura T; Ribas A; Rozengurt N; Lawson GW; Faure-Kumar E; Wang HJ; Herschman H; Kasahara N; Stripecke R
    Mol Ther; 2007 May; 15(5):971-80. PubMed ID: 17375074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivirus-induced dendritic cells for immunization against high-risk WT1(+) acute myeloid leukemia.
    Sundarasetty BS; Singh VK; Salguero G; Geffers R; Rickmann M; Macke L; Borchers S; Figueiredo C; Schambach A; Gullberg U; Provasi E; Bonini C; Ganser A; Woelfel T; Stripecke R
    Hum Gene Ther; 2013 Feb; 24(2):220-37. PubMed ID: 23311414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of dendritic cells loaded with a fusion mRNA encoding tyrosinase-related protein 2 and enhanced green fluorescence protein on B16 melanoma.
    Fukui M; Nakano-Hashimoto T; Okano K; Maruta Y; Suehiro Y; Hamanaka Y; Yamashita H; Imai K; Kawano MM; Hinoda Y
    Tumour Biol; 2004; 25(5-6):252-7. PubMed ID: 15627888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro.
    Ahmed Ali HA; Di J; Mei W; Zhang YC; Li Y; Du ZW; Zhang GZ
    Asian Pac J Cancer Prev; 2014; 15(2):611-6. PubMed ID: 24568466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
    Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L
    J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen.
    Chen JH; Yu YS; Chen XH; Liu HH; Zang GQ; Tang ZH
    World J Gastroenterol; 2012 Mar; 18(12):1319-27. PubMed ID: 22493545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trp2 Peptide-Assembled Nanoparticles with Intrinsically Self-Chelating
    He Z; Jia H; Zheng M; Wang H; Yang W; Gao L; Zhang Z; Xue J; Xu B; Yang W; Xing G; Gao X; Gao F
    ACS Appl Bio Mater; 2021 Jul; 4(7):5707-5716. PubMed ID: 35006752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation.
    Sundarasetty BS; Kloess S; Oberschmidt O; Naundorf S; Kuehlcke K; Daenthanasanmak A; Gerasch L; Figueiredo C; Blasczyk R; Ruggiero E; Fronza R; Schmidt M; von Kalle C; Rothe M; Ganser A; Koehl U; Stripecke R
    J Transl Med; 2015 Jul; 13():240. PubMed ID: 26198406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.
    Panelli MC; Wunderlich J; Jeffries J; Wang E; Mixon A; Rosenberg SA; Marincola FM
    J Immunother; 2000; 23(4):487-98. PubMed ID: 10916759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
    J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy.
    Morante V; Borghi M; Farina I; Michelini Z; Grasso F; Gallinaro A; Cecchetti S; Di Virgilio A; Canitano A; Pirillo MF; Bona R; Cara A; Negri D
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.
    Salguero G; Sundarasetty BS; Borchers S; Wedekind D; Eiz-Vesper B; Velaga S; Jirmo AC; Behrens G; Warnecke G; Knöfel AK; Blasczyk R; Mischak-Weissinger E; Ganser A; Stripecke R
    Hum Gene Ther; 2011 Oct; 22(10):1209-24. PubMed ID: 21574869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes.
    Dyall J; Latouche JB; Schnell S; Sadelain M
    Blood; 2001 Jan; 97(1):114-21. PubMed ID: 11133750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.
    Schreurs MW; Eggert AA; de Boer AJ; Vissers JL; van Hall T; Offringa R; Figdor CG; Adema GJ
    Cancer Res; 2000 Dec; 60(24):6995-7001. PubMed ID: 11156402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen.
    Sun Y; Song M; Stevanović S; Jankowiak C; Paschen A; Rammensee HG; Schadendorf D
    Int J Cancer; 2000 Aug; 87(3):399-404. PubMed ID: 10897046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells.
    Pincha M; Salguero G; Wedekind D; Sundarasetty BS; Lin A; Kasahara N; Brugman MH; Jirmo AC; Modlich U; Gutzmer R; Büsche G; Ganser A; Stripecke R
    Gene Ther; 2011 Aug; 18(8):750-64. PubMed ID: 21412283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.